Alnylam Pharmaceuticals, Inc. (ALNY) vs Vertex Pharmaceuticals Incorporated (VRTX)

• Alnylam Pharmaceuticals, Inc. ALNY 231.83 ▼ −0.94%
• Vertex Pharmaceuticals Incorporated VRTX 499.39 ▼ −1.84%

Alnylam Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $129.0B against $31.3B — 4.1× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 28.8× against 39.5×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against 10.2%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 16.1%) and the higher return on invested capital (24.1% vs 0.00%). Across the 22 metrics below, Vertex Pharmaceuticals Incorporated leads on 16 and Alnylam Pharmaceuticals, Inc. on 6.